Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Willa Durose

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 13, 2026
Promoting donor microglial replacement through augmented conditioning or radiation sensitivityTroy C Lund, Willa Durose, Emma Schindhelm, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 7, 2024
Secondary failure of lentiviral vector gene therapy in a cerebral adrenoleukodystrophy patient with an ABCD1 whole-gene deletionTroy C Lund, Paul J Orchard, David R Nascene, et al.
Journal of Neuroimmunology|June 19, 2024
Targeting VEGF-mediated blood-brain barrier disruption in advanced cerebral leukodystrophyAshish O Gupta, Justin W Furcich, David R Nascene, et al.
Blood Advances|October 23, 2023
Loss of early myeloid donor cell engraftment into the central nervous system with nonmyeloablative conditioningErin E Nolan, Willa Durose, Leyla A Taghizadeh, et al.
Stem Cells (Dayton, Ohio)|July 29, 2025
Loss of peroxisome function promotes oxidative stress induced hematopoiesisEmma A Schindhelm, Amada Blake, Megan M Constans, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 8, 2026
Nervonic acid supplementation mitigates disease severity biomarkers in adrenoleukodystrophyChenxu Li, Kai Braaten, Ann B Moser, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 7, 2025
Remodeling the sarcoma microenvironment by simultaneous targeting of urokinase-type plasminogen activator receptors and epidermal growth factor receptors to promote antitumor activityAshley J Schulte, Mitzi Lewellen, Willa Durose, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 13, 2026
Promoting donor microglial replacement through augmented conditioning or radiation sensitivityTroy C Lund, Willa Durose, Emma Schindhelm, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 7, 2024
Secondary failure of lentiviral vector gene therapy in a cerebral adrenoleukodystrophy patient with an ABCD1 whole-gene deletionTroy C Lund, Paul J Orchard, David R Nascene, et al.
Journal of Neuroimmunology|June 19, 2024
Targeting VEGF-mediated blood-brain barrier disruption in advanced cerebral leukodystrophyAshish O Gupta, Justin W Furcich, David R Nascene, et al.
Blood Advances|October 23, 2023
Loss of early myeloid donor cell engraftment into the central nervous system with nonmyeloablative conditioningErin E Nolan, Willa Durose, Leyla A Taghizadeh, et al.
Stem Cells (Dayton, Ohio)|July 29, 2025
Loss of peroxisome function promotes oxidative stress induced hematopoiesisEmma A Schindhelm, Amada Blake, Megan M Constans, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 8, 2026
Nervonic acid supplementation mitigates disease severity biomarkers in adrenoleukodystrophyChenxu Li, Kai Braaten, Ann B Moser, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 7, 2025
Remodeling the sarcoma microenvironment by simultaneous targeting of urokinase-type plasminogen activator receptors and epidermal growth factor receptors to promote antitumor activityAshley J Schulte, Mitzi Lewellen, Willa Durose, et al.
Pageof 1